Medy-Tox Inc 086900
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₩70,700.00
- Day Range
- ₩70,000.00–72,000.00
- 52-Week Range
- ₩61,200.00–138,800.00
- Bid/Ask
- ₩69,900.00 / ₩70,000.00
- Shares Outstanding
- 6.46M
- Market Cap
- ₩454.66B
- Volume/Avg
- 15,724 / 24,559
Key Statistics
- Price/Earnings (Normalized)
- 22.50
- Price/Sales
- 1.83
- Dividend Yield (Trailing)
- 1.70%
- Dividend Yield (Forward)
- 1.70%
- Dividend Payment Schedule
- Nov
- Total Yield
- 4.56%
Company Profile
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 761
- Website
- https://www.medytox.com
Valuation
Metric | 086900 |
|---|---|
Price/Earnings (Normalized) | 22.50 |
Price/Book Value | 1.18 |
Price/Sales | 1.83 |
Price/Cash Flow | 10.72 |
Price/Earnings
086900
Financial Strength
Metric | 086900 |
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 1.13 |
Interest Coverage | — |
Quick Ratio
086900
Profitability
Metric | 086900 |
|---|---|
Return on Assets (Normalized) | 2.52% |
Return on Equity (Normalized) | 3.41% |
Return on Invested Capital (Normalized) | 2.78% |
Return on Assets
086900
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|#xJ&D%$ | LOCK|@%!? | $136B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|nTp$#F | LOCK|$@^@ | $99B | |||
| Moderna Inc MRNA | LOCK|$?ttpk | LOCK|h# | $87B | |||
| argenx SE ADR ARGX | LOCK|PsD?TZ | LOCK|T^ | $61B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|dzQ#l^ | LOCK|nR | $48B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|lH!F#Lj | LOCK|@Dy@ | $31B | |||
| Incyte Corp INCY | LOCK|hl#^%Zg | LOCK|bQk | $25B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|zJG&VJ | LOCK|WZjz | $21B | |||
| BioNTech SE ADR BNTX | LOCK|?&^qkrr | LOCK|&V | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|$@@RYr# | LOCK|WB | $15B |